Pfizer (PFE) Preferred Shares (2009 - 2020)

Pfizer (PFE) has reported Preferred Shares for 12 consecutive years, with $17.0 million the latest figure, recorded in Q1 2020.

• On a quarterly basis, Preferred Shares fell 10.53% year-over-year to $17.0 million in Q1 2020; TTM through Mar 2020 was $17.0 million, a 10.53% decrease from a year earlier, with the FY2019 full-year figure at $17.0 million, down 10.53% from the prior year.
• Preferred Shares was $17.0 million for Q1 2020 at Pfizer, roughly flat from $17.0 million in the prior quarter.
• Over five years, Preferred Shares peaked at $26.0 million in Q2 2016 and troughed at $17.0 million in Q4 2019.
• A 5-year average of $21.1 million and a median of $21.0 million in 2017 frame the typical range for Preferred Shares.
• Across the five-year window, Preferred Shares declined 7.14% in 2016 and declined 13.04% in 2018, its largest moves.
• Over 5 years, Preferred Shares stood at $24.0 million in 2016, then declined by 12.5% to $21.0 million in 2017, then dropped by 9.52% to $19.0 million in 2018, then retreated by 10.53% to $17.0 million in 2019, then changed by 0.0% to $17.0 million in 2020.
• The last three Preferred Shares figures came in at $17.0 million (Q1 2020), $17.0 million (Q4 2019), and $18.0 million (Q3 2019), per Business Quant data.